Risk Factors Associated with the Development of Infection with Linezolid‐ and Vancomycin‐ResistantEnterococcus faecium
- 15 November 2002
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 35 (10) , 1269-1272
- https://doi.org/10.1086/344177
Abstract
This retrospective cohort study revealed that linezolid resistance in vancomycin-resistant Enterococcus faecium was dependent on prior linezolid exposure and duration of linezolid therapy. These strains of E. faecium were resistant to the entire class of oxazolidinones.Keywords
This publication has 9 references indexed in Scilit:
- Nosocomial Spread of Linezolid-Resistant, Vancomycin-ResistantEnterococcus faeciumNew England Journal of Medicine, 2002
- Treatment of Vancomycin‐ResistantEnterococcus faeciumInfections with Quinupristin/DalfopristinClinical Infectious Diseases, 2001
- Linezolid resistance in a clinical isolate of Staphylococcus aureusThe Lancet, 2001
- Resistance to Linezolid: Characterization of Mutations in rRNA and Comparison of Their Occurrences in Vancomycin-Resistant EnterococciAntimicrobial Agents and Chemotherapy, 2001
- Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolidThe Lancet, 2001
- Linezolid and Reversible MyelosuppressionJAMA, 2001
- Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center 1 1Edited by D. E. DraperJournal of Molecular Biology, 1999
- The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faeciumJournal of Antimicrobial Chemotherapy, 1999
- Spread of Vancomycin-Resistant Enterococci: Why Did It Happen in the United States?Infection Control & Hospital Epidemiology, 1998